1 Min Read
Aug 30 (Reuters) - ICAD Inc
* ICAD Inc - announces approval of Xoft Axxent balloon applicators by China Food & Drug Administration for treatment of early-stage breast cancer Source text for Eikon: Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2017 Reuters. All Rights Reserved.